Karina Newhall1, Mary Burnette2, Benjamin S Brooke3, Andres Schanzer4, TzeWoei Tan5, Susan Flocke6, Alik Farber7, Philip Goodney8. 1. Department of Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH. Electronic address: karina.a.newhall@hitchcock.org. 2. Department of Psychiatry, Geisel School of Medicine at Dartmouth, Lebanon, NH. 3. Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah. 4. Division of Vascular and Endovascular Surgery, University of Massachusetts Medical School, Worcester, Mass. 5. Department of Vascular Surgery, Louisiana State University Medical Center, New Orleans, La. 6. Department of Family Medicine and Community Health, Case Western Reserve University School of Medicine, Cleveland, Ohio. 7. Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston, Mass. 8. Section of Vascular Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH.
Abstract
OBJECTIVE: Although smoking cessation is a key priority emphasized by professional societies and multidisciplinary consensus guidelines, significant variation exists in the methods and efficacy of smoking cessation treatment practiced by vascular surgeons. We conducted a series of patient, surgeon, and nonpatient stakeholder focus groups to identify important domains for establishment of a successful smoking cessation program. METHODS: As part of a planning effort for a randomized clinical trial on usual care vs a standardized, evidence-based smoking cessation intervention, our group performed a series of interviews and focus groups. These were four 1-hour interviews, conducted with stakeholders such as tobacco cessation counselors (n = 2), a Quit Line representative (n = 1), and a Vascular Quality Initiative leader (n = 1), as well as two 90-minute, formal, professionally moderated focus groups, one with vascular surgeons (n = 7), and another with patients (n = 4). Transcripts and audio recordings were qualitatively reviewed for themes to establish the most important domains perceived to be associated with a successful smoking cessation program. RESULTS: Patients emphasized four domains critical for a successful smoking cessation program: the motivation to quit, an individualized approach, the timing of an intervention, and the tone of the physician who offers counseling. Although surgeons and nonpatient stakeholders also emphasized the importance of a compassionate physician tone, surgeons and nonpatient stakeholders differed from patients in their remaining domains. They emphasized the feasibility of a brief intervention in a busy clinical practice, implementation of the effort, and necessary infrastructure for smoking cessation programs. All focus group participants described a brief, evidence-based smoking cessation intervention as feasible in routine vascular practice. CONCLUSIONS: Differences in motivation and significance exist for patients, surgeons, and stakeholders when they considered the specific domains most important in building a successful smoking cessation program. Despite these differences, all parties involved agreed that a brief, standardized intervention can be successful delivered in a busy vascular clinic setting. Published by Elsevier Inc.
RCT Entities:
OBJECTIVE: Although smoking cessation is a key priority emphasized by professional societies and multidisciplinary consensus guidelines, significant variation exists in the methods and efficacy of smoking cessation treatment practiced by vascular surgeons. We conducted a series of patient, surgeon, and nonpatient stakeholder focus groups to identify important domains for establishment of a successful smoking cessation program. METHODS: As part of a planning effort for a randomized clinical trial on usual care vs a standardized, evidence-based smoking cessation intervention, our group performed a series of interviews and focus groups. These were four 1-hour interviews, conducted with stakeholders such as tobacco cessation counselors (n = 2), a Quit Line representative (n = 1), and a Vascular Quality Initiative leader (n = 1), as well as two 90-minute, formal, professionally moderated focus groups, one with vascular surgeons (n = 7), and another with patients (n = 4). Transcripts and audio recordings were qualitatively reviewed for themes to establish the most important domains perceived to be associated with a successful smoking cessation program. RESULTS:Patients emphasized four domains critical for a successful smoking cessation program: the motivation to quit, an individualized approach, the timing of an intervention, and the tone of the physician who offers counseling. Although surgeons and nonpatient stakeholders also emphasized the importance of a compassionate physician tone, surgeons and nonpatient stakeholders differed from patients in their remaining domains. They emphasized the feasibility of a brief intervention in a busy clinical practice, implementation of the effort, and necessary infrastructure for smoking cessation programs. All focus group participants described a brief, evidence-based smoking cessation intervention as feasible in routine vascular practice. CONCLUSIONS: Differences in motivation and significance exist for patients, surgeons, and stakeholders when they considered the specific domains most important in building a successful smoking cessation program. Despite these differences, all parties involved agreed that a brief, standardized intervention can be successful delivered in a busy vascular clinic setting. Published by Elsevier Inc.
Authors: John Castaldo; Jane Nester; Tom Wasser; Tamara Masiado; Michael Rossi; Mark Young; Joseph J Napolitano; J Sanford Schwartz Journal: Dis Manag Date: 2005-04
Authors: Andrew W Hoel; Brian W Nolan; Philip P Goodney; Yuanyuan Zhao; Andres Schanzer; Andrew C Stanley; Jens Eldrup-Jorgensen; Jack L Cronenwett Journal: J Vasc Surg Date: 2013-01-30 Impact factor: 4.268
Authors: Khaled M Musallam; Frits R Rosendaal; Ghazi Zaatari; Assaad Soweid; Jamal J Hoballah; Pierre M Sfeir; Salah Zeineldine; Hani M Tamim; Toby Richards; Donat R Spahn; Luca A Lotta; Flora Peyvandi; Faek R Jamali Journal: JAMA Surg Date: 2013-08 Impact factor: 14.766
Authors: Karina Newhall; Bjoern Suckow; Emily Spangler; Benjamin S Brooke; Andres Schanzer; Tze-Woei Tan; Mary Burnette; Maria Orlando Edelen; Alik Farber; Philip Goodney Journal: Ann Vasc Surg Date: 2016-08-10 Impact factor: 1.466
Authors: Barbara Riegel; Debra K Moser; Harleah G Buck; Victoria Vaughan Dickson; Sandra B Dunbar; Christopher S Lee; Terry A Lennie; JoAnn Lindenfeld; Judith E Mitchell; Diane J Treat-Jacobson; David E Webber Journal: J Am Heart Assoc Date: 2017-08-31 Impact factor: 5.501